Editorial Comment on “Quantitative Assessment of Additive Effects Of mirabegron and Solifenacin in Overactive Bladder: Re-analysis of SYNERGY Study”

Posted by author-avatar

Publication date: Available online 23 July 2026

Source: Urology

Author(s): Hann-Chorng Kuo

Read More

Newer
Testosterone Deficiency in the National Spotlight: An Opportunity to Get It Right
Older Editorial Comment on “Implications of Alpha Gal Syndrome in Urologic Management”